Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $62,606 | 23 | 56.7% |
| Consulting Fee | $28,360 | 9 | 25.7% |
| Food and Beverage | $12,384 | 515 | 11.2% |
| Travel and Lodging | $4,940 | 26 | 4.5% |
| Honoraria | $1,225 | 1 | 1.1% |
| Education | $498.94 | 11 | 0.5% |
| Gift | $413.92 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teleflex LLC | $68,405 | 54 | $0 (2024) |
| PALETTE LIFE SCIENCES, INC. | $28,028 | 32 | $0 (2023) |
| Dendreon Pharmaceuticals LLC | $2,094 | 37 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $1,547 | 15 | $0 (2023) |
| Astellas Pharma US Inc | $1,493 | 74 | $0 (2024) |
| Janssen Biotech, Inc. | $1,169 | 62 | $0 (2024) |
| Medtronic, Inc. | $646.65 | 22 | $0 (2023) |
| ABBVIE INC. | $624.43 | 31 | $0 (2024) |
| Medtronic USA, Inc. | $546.50 | 18 | $0 (2020) |
| Axonics, Inc. | $515.54 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $69,373 | 109 | Teleflex LLC ($68,127) |
| 2023 | $31,601 | 113 | PALETTE LIFE SCIENCES, INC. ($27,628) |
| 2022 | $1,987 | 87 | Palette Life Sciences, Inc. ($399.96) |
| 2021 | $1,328 | 72 | Astellas Pharma US Inc ($224.35) |
| 2020 | $2,108 | 39 | Dendreon Pharmaceuticals LLC ($1,375) |
| 2019 | $1,151 | 51 | Astellas Pharma US Inc ($199.92) |
| 2018 | $1,327 | 61 | Janssen Biotech, Inc. ($289.41) |
| 2017 | $1,553 | 54 | NxThera, Inc. ($425.02) |
All Payment Transactions
586 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/20/2024 | Teleflex LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,362.50 | General |
| 12/18/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/13/2024 | Axonics, Inc. | Bulkamid (Device), Axonics | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: Urology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Oncology | ||||||
| 12/06/2024 | Teleflex LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,500.00 | General |
| 12/06/2024 | Teleflex LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| 12/06/2024 | Teleflex LLC | — | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| 12/06/2024 | Teleflex LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| 12/06/2024 | Teleflex LLC | — | Travel and Lodging | Cash or cash equivalent | $730.95 | General |
| 12/06/2024 | Teleflex LLC | — | Travel and Lodging | Cash or cash equivalent | $73.97 | General |
| 12/06/2024 | Teleflex LLC | — | Travel and Lodging | Cash or cash equivalent | $44.00 | General |
| 12/06/2024 | Teleflex LLC | — | Food and Beverage | Cash or cash equivalent | $28.40 | General |
| 12/06/2024 | Teleflex LLC | — | Food and Beverage | Cash or cash equivalent | $6.99 | General |
| 12/05/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/05/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug), Nubeqa | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Oncology | ||||||
| 11/11/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/08/2024 | Teleflex LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,587.50 | General |
| 11/08/2024 | Teleflex LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,137.50 | General |
| 11/08/2024 | Teleflex LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,137.50 | General |
| 11/08/2024 | Teleflex LLC | — | Travel and Lodging | Cash or cash equivalent | $95.81 | General |
| 11/08/2024 | Teleflex LLC | — | Travel and Lodging | Cash or cash equivalent | $38.39 | General |
| 11/06/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Immunotherapy | ||||||
| 11/01/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 42 | 3,484 | 24,705 | $1.7M | $435,838 |
| 2022 | 45 | 3,402 | 16,044 | $1.2M | $303,981 |
| 2021 | 44 | 3,847 | 17,351 | $1.4M | $313,227 |
| 2020 | 48 | 4,111 | 17,796 | $1.8M | $440,183 |
All Medicare Procedures & Services
182 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 30 | 7,620 | $317,525 | $141,095 | 44.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 177 | 211 | $154,030 | $35,359 | 23.0% |
| 55874 | Injection of biodegradable material next to prostate | Office | 2023 | 15 | 15 | $126,675 | $33,776 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 220 | 362 | $95,930 | $33,759 | 35.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 26 | 189 | $283,500 | $25,027 | 8.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 242 | 290 | $52,200 | $15,999 | 30.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 47 | 281 | $34,844 | $13,467 | 38.6% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 42 | 262 | $32,226 | $12,311 | 38.2% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 58 | 58 | $39,150 | $11,717 | 29.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 60 | 82 | $29,110 | $10,741 | 36.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 130 | 167 | $30,561 | $10,598 | 34.7% |
| J9155 | Injection, degarelix, 1 mg | Office | 2023 | 11 | 2,640 | $26,400 | $8,511 | 32.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 65 | 65 | $26,000 | $7,377 | 28.4% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 69 | 77 | $20,867 | $6,156 | 29.5% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 248 | 261 | $33,930 | $5,659 | 16.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 505 | 660 | $7,260 | $5,452 | 75.1% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 38 | 95 | $14,535 | $4,307 | 29.6% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 77 | 82 | $15,088 | $4,245 | 28.1% |
| 77078 | Ct scan for measuring calcium and other minerals in bone | Office | 2023 | 51 | 51 | $12,495 | $4,214 | 33.7% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 20 | 1,750 | $11,200 | $3,842 | 34.3% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 38 | 104 | $9,776 | $3,716 | 38.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 34 | 42 | $11,214 | $3,697 | 33.0% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 31 | 55 | $11,825 | $3,686 | 31.2% |
| 55874 | Injection of biodegradable material next to prostate | Facility | 2023 | 25 | 25 | $203,315 | $3,176 | 1.6% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 12 | 13 | $13,520 | $3,134 | 23.2% |
About Daniel Welchons
Daniel Welchons is a Urology healthcare provider based in New Hartford, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2010. The National Provider Identifier (NPI) number assigned to this provider is 1568786366.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Welchons has received a total of $110,428 in payments from pharmaceutical and medical device companies, with $69,373 received in 2024. These payments were reported across 586 transactions from 54 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($62,606).
As a Medicare-enrolled provider, Welchons has provided services to 14,844 Medicare beneficiaries, totaling 75,896 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 182 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location New Hartford, NY
- Active Since 03/23/2010
- Last Updated 04/09/2015
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1568786366
Products in Payments
- PROVENGE (Drug) $2,109
- PROLARIS (Device) $1,281
- INTERSTIM (Device) $916.81
- ERLEADA (Drug) $715.08
- XTANDI (Drug) $601.61
- Erleada (Drug) $490.91
- Rezum (Device) $425.02
- BOTOX (Biological) $408.62
- LYNPARZA (Drug) $379.24
- KEYTRUDA (Biological) $337.06
- Xtandi (Drug) $335.44
- Bulkamid (Device) $310.80
- UroLift (Device) $294.78
- UROLIFT (Device) $249.65
- Myrbetriq (Drug) $239.38
- ELIGARD (Drug) $232.65
- LUPRON DEPOT (Drug) $230.17
- MYRBETRIQ (Drug) $224.00
- GEMTESA (Drug) $219.61
- Axonics (Device) $190.89
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in New Hartford
Anuj Chopra, Md, MD
Urology — Payments: $50,336
Jeffrey Sekula, M.d, M.D
Urology — Payments: $15,054
Ronald Kaye, M.d, M.D
Urology — Payments: $13,095
Jonathan Block, M.d, M.D
Urology — Payments: $12,684
Robert Fleischer, Md, MD
Urology — Payments: $5,072
Dr. Naeem Samad, Md, MD
Urology — Payments: $765.54